Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	3.12	41.96	40.69
Graham Fair Price	-1.79	24.16	24.60
PEG	967.73	-2.01	0.19
Price/Book	-1.24	2.24	2.27
Price/Cash Flow	256.66	51.85	14.54
Prices/Earnings	12.00	15.49	13.83
Price/Sales	-6.78	8.17	8.77
Price/FCF	256.66	51.85	14.54
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-39.00	0.26	0.43
Operating Margin	-9.06	0.19	0.21
ROA	-8.17	< 0.005	< 0.005
ROE	0.04	0.04	-11.82
ROIC	0.01	0.01	2.77
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.01	0.01	-8.43
Dividends QOQ	-0.02	0.83	4404.26
EBIT QOQ	0.50	0.01	-97.03
EPS QOQ	0.73	-0.08	-89.51
FCF QOQ	3.56	-0.71	-80.11
Revenue QOQ	0.17	0.12	-30.00
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	75.58	37.87	-49.89
Days Sales Outstanding (DSO)	43.57	37.14	-14.75
Inventory Turnover	1.19	2.38	99.58
Debt/Capitalization	0.67	0.66	-1.49
Quick Ratio	0.40	0.77	89.48
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	25.63	26.80	4.58
Cash	0.77	2.90	276.61
Capex	2.62	-2.07	-21.06
Free Cash Flow	3.99	1.16	-71.04
Revenue	6.62	7.34	10.80
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.98	1.35	37.34
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	19.29	19.16	-0.69
Naive Interpretation	Member

06 - Financial Health · Weak

Rating